The CIpP activator, TR-57, is highly effective as a single agent and in combination with venetoclax against CLL cells in vitro
Fatima, Narjis, Shen, Yandong, Crassini, Kyle, Burling, Olivia, Thurgood, Lauren, Iwanowicz, Edwin J, Lang, Henk, Karanewsky, Donald S, Christopherson, Richard I, Mulligan, Stephen P, Best, O Giles
Published in Leukemia & lymphoma (01.05.2024)
Published in Leukemia & lymphoma (01.05.2024)
Get more information
Journal Article